← Browse by Condition
Medical Condition
locally advanced malignant solid neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT03907475 Phase 2
Recruiting
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Enrollment
115 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...